Novocure Expects Top-line Data From Phase 3 PANOVA-3 Clinical Trial in Locally Advanced Pancreatic Cancer in Q4
Novocure Expects Top-line Data From Phase 3 PANOVA-3 Clinical Trial in Locally Advanced Pancreatic Cancer in Q4
Novocure 预计将在第四季度获得针对局部晚期胰腺癌的 3 期 PANOVA-3 临床试验的主要数据
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册